Implantable ventricular assist devices: Is it time to introduce them in Canada?

Canadian Journal of Cardiology

Volumn 16, Issue 5, 2000, Pages 629-640

  McGregor, Maurice ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Circulation; Heart assist device; Ventricles

Indexed keywords

ARTICLE; ASSISTED CIRCULATION; BLEEDING; CANADA; COST BENEFIT ANALYSIS; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; HUMAN; IMPLANT; INFECTION; MEDICAL ETHICS; QUALITY OF LIFE; SURVIVAL RATE; THROMBOEMBOLISM;

ADULT; CANADA; COST-BENEFIT ANALYSIS; EMERGENCY TREATMENT; ETHICS, MEDICAL; HEALTH CARE COSTS; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEMORRHAGE; HUMANS; PROSTHESIS-RELATED INFECTIONS; QUALITY OF LIFE; SOCIAL RESPONSIBILITY; THROMBOEMBOLISM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034076977     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6.
2. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998;339:1522-33.
3. Hunt SA, Frazier OH. Mechanical circulatory support and cardiac transplantation. Circulation 1998;97:2079-90.
4. Oregon Health Resources Commission. Medical Technology Assessment and Health Resources Plan for Ventricular Assist Devices. Salem: Oregon Health Plan Policy and Research. Health Resources Commission. 1998:29.
5. Jouveshomme S, Baffert S, Fay A-F. Coeur Artificiel (III). Dossier CEDIT 1998;Sept:35.
6. Christopher F, Clegg A. Left Ventricular Assist Devices (LVADs) for end stage heart failure. Development and Evaluation Committee Report No 103. Southampton: Wessex Institute for Health Research and Development, 1999. [http://www.epi.bris.ac.uk/rd]
7. Novacor LVAS. Wearable Electric Heart Assist System. Oakland: Baxter Healthcare Corporation, 1999.
8. Jansen PJM, Wheeldon OR, Portner PM. Long-term home discharge support with Novacor LVAS. J Heart Lung Transplant 1999;18:67-8. (Abst)
9. McCarthy PM, Smedira NO, Vargo RL, et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg 1998;115:904-12.
10. DeRose JJ, Umana JP, Argenziano M, et al. Improved results for postcardiotomy cardiogenic shock with the use of implantable left ventricular assist devices, Ann Thorac Surg 1997;64:1757-63.
11. Frazier OH, Macris MP, Myers TJ, et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg 1994;57:1416-22.
12. Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 1995;222:327-36.
13. Ashton RC Jr, Goldstein DJ, Rose EA, Weinberg AD, Levin HR, Oz MC. Duration of left ventricular assist device support affects transplant survival. J Heart Lung Transplant 1996;15:1151-7.
14. Griffith BP, Kormos RL, Nastala CJ, Winowich S, Pristas JM. Results of extended bridge to transplantation: window into the future of permanent ventricular assist devices. Ann Thorac Surg 1996;61:396-8.
15. Adamson RM, Dembitsky WP, Jaski BE, et al. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency. ASAIO J 1997;43:365-9.
16. Levin HR, Oz ML, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilatation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995;91:2712-20.
17. Muller J, Wallukat O, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997;96:542-9.
18. DeRose JJ, Argenziano M, Sun BC, Reemtsma K, Oz MC, Rose EA. Implantable left ventricular assist devices: an evolving long-term cardiac replacement therapy. Ann Surg 1997;226:461-8.
19. Frazier OH, Myers TJ, Radovancevic B. The HeartMate left ventricular assist system. Overview and 12-year experience. Tex Heart Inst J 1998;25:265-71.
20. Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998;98:2383-9.
21. Mueller J. Lessons learned from patients after weaning from LVAD: Four years of experience and follow-up. International Society for Heart and Lung Transplantation. Conference on Mechanical Cardiac Support and Replacement. Atlanta, November 5 to 6, 1999.
22. Oz MC, Argenziano M, Catanese KA, et al. Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation 1997;95:1844-52.
23. Holman WL, Bourge RC, Spruell RD, Murrah CP, McGiffin DC, Kirkin JK. Ventricular assist devices as a bridge to cardiac transplantation. A prelude to destination therapy. Ann Surg 1997;225:695-706.
24. Chillcott SR, Atkins PJ, Adamson RM. Left ventricular assist as a viable alternative for cardiac transplantation. Crit Care Nurs Q 1998;20:64-79.
25. Piccione W Jr. Mechanical circulatory assistance: changing indications and options. J Heart Lung Transplant 1997;16(Suppl):S25-8.
26. ThermoCardiosystems Inc. Worlwide Registry, October 1999. Woburn: ThermoCardiosystems Inc, 1999.
27. Poirier VL. Worldwide experience with the TCI HeartMate system: issues and future perspective. Thorac Cardiovasc Surg 1999;47(Suppl 2):316-20.
28. Sun BC, Catanese KA, Spanier TB, et al. 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann Thorac Surg 1999;68:688-94.
29. El-Banayosy A, Deng M, Loisance DY, et al. The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study. Eur J Cardiothorac Surg 1999;15:835-41.
30. Smedira MG. 200 Implantable LVADs: Have things changed since the first 100? International Society for Heart and Lung Transplantation. Conference on Mechanical Cardiac Support and Replacement. Atlanta, November 5 to 6, 1999.
31. Pae W. Thoratec and ThermoCardio Systems. Pneumatic left ventricular systems as a bridge to transplant: An institutional experience. International Society for Heart and Lung Transplantation. Conference on Mechanical Cardiac Support and Replacement. Atlanta, November 5 to 6, 1999.
32. McCarthy PM, Sabik JF. Implantable circulatory support devices as a bridge to heart transplantation. Semin Thorac Cardiovasc Surg 1994;6:174-80.
33. Schmid C, Weyand M, Hammel D, Deng MC, Nabavi D, Scheld HH. Effect of platelet inhibitors on thromboembolism after implantation of a Novacor N100 - preliminary results. Thorac Cardiovasc Surg 1998;46:260-2.
34. Schmid C, Weyand M, Nabavi DG, et al. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg 1998;65:1703-10.
35. Portner PM. Novacor left ventricular assist system. International Society for Heart and Lung Transplantation. Conference on Mechanical Cardiac Support and Replacement. Atlanta, November 5 to 6, 1999.
36. Holman WL, Murrah CP, Ferguson ER, Bourge RC, McGiffin DC, Kirklin JK. Infections during extended circulatory support: University of Alabama at Birmingham experience 1989 to 1994. Ann Thorac Surg 1996;61:366-71.
37. Kormos RL. Unresolved issues in long-term mechanical circulatory support. International Society for Heart and Lung Transplantation. Conference on Mechanical Cardiac Support and Replacement. Atlanta, November 5 to 6, 1999.
38. Argenziano M, Catanese KA, Moazami N, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant 1997;16:822-31.
39. Holman WL, Skinner JL, Waites KB, et al. Infection during circulatory support with ventricular assist devices. Ann Thorac Surg 1999;68:711-6.
40. Kormos RL, Ramasamy N, Sit S, Cleeland AD, Jassawala JS, Portner PM. Bridge-to-transplant (BIT) experience with the Novacor left ventricular assist system (LVAS): Results of a multicenter US study. J Heart Lung Transplant 1999;18:63. (Abst 115)
41. Koul B, Solem J-O, Steen S, Gasimir-Ahn H, Granfeldt H, Lönn UJ. HeartMate left ventricular assist device. Ann Thorac Surg 1998;65:1625-30.
42. Myers TJ, Catanese KA, Vargo RL, Dressler DK. Extended cardiac support with a portable left ventricular assist system in the home. ASAIO J 1996;42:M576-9.
43. Catanese KA, Goldstein DJ, Williams DL, et al. Outpatient left ventricular assist device support: a destination rather than a bridge. Ann Thorac Surg 1996;62:646-53.
44. Dew MA, Kormos RL, Winowich S, et al. Quality of life outcomes in left ventricular assist system inpatients and outpatients. ASAIO J 1999;45:218-25.
45. Moskowitz AJ, Weinberg AD, Oz MC, Williams DL. Quality of life with an implanted left ventricular assist device. Ann Thorac Surg 1997;64:1764-9.
46. Shapiro PA, Levin HR, Oz MC. Left ventricular assist devices. Psychosocial burden and implications for heart transplant programs. Gen Hosp Psychiatry 1996;18(6 Suppl):30S-5S.
47. Consumer Prices and Price Indexes [Cat 62-010]. Ottawa: Statistics Canada, 1998.
48. Gelijns AC, Richards AF, Williams DL, Oz MC, Oliveira J, Moskowitz AJ. Evolving costs of long-term left ventricular assist device imlantation. Ann Thorac Surg 1997;64:1312-9.
49. Conseil d'évaluation des technologies de la santé du Canada. La transplantation cardiaque au Canada: Le taux de survie, les coûts et le rapport coût-efficacité. Montréal: Conseil d'évaluation des technologies de la santé du Canada, 1992.
50. Schmid C, Deng M, Hammel D, Weyand M, Loick HM, Scheld HH. Emergency versus elective/urgent left ventricular assist device implantation. J Heart Lung Transplant 1998;17:1024-8.
51. Rose EA, Moskowitz AJ, Packer M, et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg 1999;67:723-30.
52. The International Society for Heart and Lung Transplantation. Sixteenth Annual Data Report, April 1999. http://www.ishlt.org/registry.html.
53. Van Meter CH Jr, Smart FW, Stapleton DD, Ventura HO, Ochsner JL. Mechanical assistance of the failing heart in the elderly. Cardiol Elder 1999;160:1557-63.
54. Schaubel DE, Morrison HI, Desmeules M, Parsons DA, Fenton SSA. End-stage renal disease in Canada: prevalence projections to 2005. CMAJ 1999;160:1557-63.
55. . Conseil d'évaluation des technologies de la santé du Canada. Hémodialyse et dialyse péritoneale: Analyse comparative des rapports coût-efficacité. Montréal: Conseil d'évaluation des technologies de la santé du Canada, 1998.
56. Mussivand T, Hendry PJ, Masters RG, King M, Holmes KS, Keon WJ. Progress with the HeartSaver ventricular assist device. Ann Thorac Surg 1999;68:785-9.
57. . United Network for Organ Sharing. Patient Survival Rates at One Month and at One, Three and Five Years. Table 40. Heart Transplants. (September 1998) http://www.unos.org/data/anrpt98/ar98_table40_01_hr.htm.
58. Joyce LD, Kiser JC, Eales F, King RM, Overton JW Jr, Toninato CJ. Experience with generally accepted centrifugal pumps: personal and collective experience. Ann Thorac Surg 1996;61:287-90.